Spark Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Spark Investment Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-14,700	Closed	-$191K	–	942
2016 Q2	$191K	Sell	14,700 -43,500	-75%	-$570K	0.02%	630
2016 Q1	$640K	Hold	58,200	–	–	0.06%	388
2015 Q4	$535K	Hold	58,200	–	–	0.07%	364
2015 Q3	$402K	Sell	58,200 -37,700	-39%	-$323K	0.05%	412
2015 Q2	$941K	Hold	95,900	–	–	0.13%	229
2015 Q1	$849K	Hold	95,900	–	–	0.12%	250
2014 Q4	$840K	Buy	95,900 +41,600	+77%	+$337K	0.14%	214
2014 Q3	$374K	Buy	+54,300	New	+$325K	0.06%	405
2013 Q4	–	Sell	-35,800	Closed	-$181K	–	746
2013 Q3	$181K	Buy	+35,800	New	+$199K	0.04%	459

Other funds holding SCLN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Spark Investment Management's SCLN Position: Q3 2016 in Review

Spark Investment Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2016, closing a stake of 14,700 shares — an estimated $191K sold.

Spark Investment Management first reported a position in SCLN in Q3 2013 and held it in 9 quarters. The position peaked at $941K in Q2 2015. 151 funds tracked by Wall St. Rank hold SCLN as of Q3 2016.

Spark Investment Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Spark Investment Management sold 14,700 Sciclone Pharmaceuticals Inc shares in Q3 2016, an estimated $191K.
Spark Investment Management first reported a position in Sciclone Pharmaceuticals Inc in Q3 2013 and held it in 9 quarters.
Spark Investment Management's Sciclone Pharmaceuticals Inc position peaked at $941K in Q2 2015.
151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2016.

Based on Spark Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.